» Articles » PMID: 38335961

ALS-related P97 R155H Mutation Disrupts Lysophagy in IPSC-derived Motor Neurons

Overview
Publisher Cell Press
Specialty Cell Biology
Date 2024 Feb 9
PMID 38335961
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the AAA+ ATPase p97 cause multisystem proteinopathy 1, which includes amyotrophic lateral sclerosis; however, the pathogenic mechanisms that contribute to motor neuron loss remain obscure. Here, we use two induced pluripotent stem cell models differentiated into spinal motor neurons to investigate how p97 mutations perturb the motor neuron proteome. Using quantitative proteomics, we find that motor neurons harboring the p97 R155H mutation have deficits in the selective autophagy of lysosomes (lysophagy). p97 R155H motor neurons are unable to clear damaged lysosomes and have reduced viability. Lysosomes in mutant motor neurons have increased pH compared with wild-type cells. The clearance of damaged lysosomes involves UBXD1-p97 interaction, which is disrupted in mutant motor neurons. Finally, inhibition of the ATPase activity of p97 using the inhibitor CB-5083 rescues lysophagy defects in mutant motor neurons. These results add to the evidence that endo-lysosomal dysfunction is a key aspect of disease pathogenesis in p97-related disorders.

Citing Articles

Ubiquitin regulatory X (UBX) domain-containing protein 6 is essential for autophagy induction and inflammation control in macrophages.

Kim Y, Lee S, Park S, Jeon S, Kim S, Kim K Cell Mol Immunol. 2024; 21(12):1441-1458.

PMID: 39438692 PMC: 11606977. DOI: 10.1038/s41423-024-01222-1.


Elevated VCP ATPase Activity Correlates With Disease Onset in Multisystem Proteinopathy-1.

Robinson S, Findlay A, Li S, Wang F, Schiava M, Daw J Neurol Genet. 2024; 10(5):e200191.

PMID: 39280885 PMC: 11398976. DOI: 10.1212/NXG.0000000000200191.

References
1.
Ritz D, Vuk M, Kirchner P, Bug M, Schutz S, Hayer A . Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat Cell Biol. 2011; 13(9):1116-23. PMC: 3246400. DOI: 10.1038/ncb2301. View

2.
Yim W, Yamamoto H, Mizushima N . Annexins A1 and A2 are recruited to larger lysosomal injuries independently of ESCRTs to promote repair. FEBS Lett. 2022; 596(8):991-1003. DOI: 10.1002/1873-3468.14329. View

3.
Zhou H, Wang J, Yao B, Wong S, Djakovic S, Kumar B . Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). J Med Chem. 2015; 58(24):9480-97. DOI: 10.1021/acs.jmedchem.5b01346. View

4.
Wang F, Li S, Wang T, Lopez G, Antoshechkin I, Chou T . P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration. Brain Commun. 2022; 4(4):fcac176. PMC: 9294923. DOI: 10.1093/braincomms/fcac176. View

5.
Gonzalez M, Feely S, Speziani F, Strickland A, Danzi M, Bacon C . A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 2014; 137(Pt 11):2897-902. PMC: 4208462. DOI: 10.1093/brain/awu224. View